June 3, 2015
Sumitomo Dainippon Pharma said on June 2 that five abstracts including the latest data on its investigational anticancer agents BBI608 and BBI503 were presented at a poster session of the 2015 American Society of Clinical Oncology’s (ASCO) annual meeting in...read more